What is new in hypertension guidelines?

Abstract

In recent years, trials were published and a series of new evidences were presented in relation to hypertension (HT), requiring changes in guidelines. In the light of these studies, the European Society of Hypertension (ESH)/European Society of Cardiology (ESC) HT guideline which was published in 2007 and reviewed in 2009 was revised. The new ESH/ESC HT 2013 guideline announced at the European Hypertension Congress in Milan was published in both Journal of Hypertension and European Heart Journal, and put at the disposal of doctors. In December 2013, the eight Joint National Committee (JNC 8) HT treatment guideline which had been expected for a long time and published online on the Journal of the American Medical Association was issued. Unlike the previous JNC guidelines and ESH/ESC HT guideline, it was a brief guideline containing only recommendations and explaining the grounds of the recommendations. A day before the publication of JNC 8 hypertension treatment guideline, American Society of Hypertension/International Society of Hypertension (ASH/ISH) HT treatment guideline was published. This guideline was also kept short like JNC 8, but contained more details. In this review, we summarized and compared the changes made in the new guidelines. J. Exp. Clin. Med., 2014; 31: 7-12

Keywords

• Antihypertensive drugs; blood pressure; guidelines; hypertension; treatment

References

1. Antihypertensive and lipid-lowering treatment to prevent heart attack trial collaborative research group, 2003. Diuretic versus alpha-blocker as first-step antihypertensive therapy: Final results from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Hypertension. 42, 239-246.
2. Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, J.L. Jr, Jones, D.W., Materson, B.J., Oparil, S., Wright, J.T. Jr., Roccella, E.J. 2003. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 42, 1206-1252.
3. Cushman, W.C., Evans, G.W., Byington, R.P., Goff, D.C. Jr., Grimm, R.H. Jr., Cutler, J.A., Simons-Morton, D.G., Basile, J.N., Corson, M.A., Probstfield, J.L., Katz, L., Peterson, K.A., Friedewald, W.T., Buse, J.B., Bigger, J.T., Gerstein, H.C., Ismail-Beigi, F., 2010. ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N. Engl. J. Med. 362, 1575-1585.
4. Dahlöf, B., Devereux, R.B., Kjeldsen, S.E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., Lindholm, L.H., Nieminen, M.S., Omvik, P., Oparil, S., Wedel, H.; LIFE Study Group, 2002. Cardiovascular morbidity and mortality in the Losartan Intervention For endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet. 359, 995-1003. Guidelines Committee, 2003. 2003 European Society of Hypertension-European Society of Cardiology Guidelines for the management of arterial hypertension. J. Hypertens. 21, 1011-1053.
5. Hypertension Detection and Follow-up Program Cooperative Group, 1979. Five-year findings of the hypertension detection and follow-up program, I: Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA. 242, 2562-2571.
6. Hypertension Detection and Follow-up Program Cooperative Group, 1982. Five-year findings of the hypertension detection and follow-up program, III: Reduction in stroke incidence among persons with high blood pressure. JAMA. 247, 633-638.
7. Hypertension-Stroke Cooperative Study Group, 1974. Effect of antihypertensive treatment on stroke recurrence. JAMA. 229, 409-418.
8. James, P.A., Oparil, S., Carter, B.L, Cushman, W.C, Dennison-Himmelfarb, C., Handler, J., Lackland, D.T, Lefevre, M.L, Mackenzie, T.D, Ogedegbe, O., Smith, S.C. Jr., Svetkey, L.P., Taler, S.J., Townsend, R.R., Wright, J.T.Jr., Narva, A.S., Ortiz, E., 2013. 2014 Evidencebased guideline for the management of high blood pressure in adults report from the panel members appointed to the eighth joint national committee (JNC 8). JAMA. Dec 18. doi: 10.1001/jama.2013.284427.

9. Mancia, G., Laurent, S., Agabiti-Rosei, E., Ambrosioni, E., Burnier, M., Caulfield, M.J., Cifkova, R., Clément, D., Coca, A., Dominiczak, A., Erdine, S., Fagard, R., Farsang, C., Grassi, G., Haller, H., Heagerty, A., Kjeldsen, S.E., Kiowski, W., Mallion, J.M., Manolis, A., Narkiewicz, K., Nilsson, P., Olsen, M.H., Rahn, K.H., Redon, J., Rodicio, J., Ruilope, L., Schmieder, R.E., Struijker-Boudier, H.A., Van Zwieten, P.A, Viigimaa, M., Zanchetti, A., 2009. Reappraisal of European guidelines on hypertension management: A European society of hypertension task force document. Blood Press. 18, 308-347. doi: 10.3109/08037050903450468.
10. Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A.M., Kjeldsen, S.E., Laurent, S., Narkiewicz, K., Ruilope, L., Rynkiewicz, A., Schmieder, R.E., Boudier, H.A., Zanchetti, A., Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen,S.D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J.L., Erdine, S., Kiowski, W., Agabiti-Rosei, E., Ambrosioni, E., Lindholm, L.H., Viigimaa, M., Adamopoulos, S., Agabiti-Rosei, E., Ambrosioni, E., Bertomeu, V., Clement, D., Erdine. S, Farsang, C., Gaita, D., Lip, G., Mallion, JM., Manolis, A.J., Nilsson, P.M., O’Brien, E., Ponikowski, P., Redon, J., Ruschitzka, F., Tamargo, J., van Zwieten, P., Waeber, B., Williams, B, Management of Arterial Hypertension of the European Society of Hypertension, European Society of Cardiology, 2007. 2007 Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 25, 1105-1187.
11. Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., Galderisi, M., Grobbee, D.E., Jaarsma,T., Kirchhof, P., Kjeldsen, S.E., Laurent, S., Manolis, A.J., Nilsson, P.M., Ruilope, L.M., Schmieder, R.E., Sirnes, P.A., Sleight, P., Viigimaa, M., Waeber, B., Zannad, F. Task Force Members, 2013. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart J. 34, 2159-2219. doi: 10.1093/eurheartj/eht151.
12. Medical Research Council Working Party,1985. MRC trial of treatment of mild hypertension: Principal results. Br. Med. J. (Clin. Res. Ed). 291, 97Report by the Management Committee, 1980. The Australian therapeutic trial in mild hypertension. Lancet. 1, 1261-1267.
13. VA Cooperative study group on antihypertensive agents. Effects of treatment on morbidity in hypertension, II: Results in patients with diastolic blood pressure averaging 90 through 114 mmHg, 1970. JAMA. 213, 1143-1152.
14. Weber, M.A., Schiffrin, E.L., White, W.B., Mann, S., Lindholm, L.H., Kenerson, J.G., Flack, J.M., Carter, B.L., Materson, B.J., Ram, C.V., Cohen, D.L., Cadet, J.C., Jean-Charles, R.R., Taler, S., Kountz, D., Townsend, R., Chalmers, J., Ramirez, A.J., Bakris, G.L., Wang, J., Schutte, A.E., Bisognano, J.D., Touyz, R.M., Sica, D., Harrap, SB., 2014. Clinical practice guidelines for the management of hypertension in the Community a Statement by the American Society of Hypertension and the International Society of Hypertension. J. Hypertens. 32, 3- doi: 10.1097/HJH.0000000000000065.